Intracellular amyloid-β in Alzheimer's disease

LaFerla, Frank M., Green, Kim N., Oddo, Salvatore·2007·Nature Reviews Neuroscience

Cited by (1,005)

Items 201–300 of 1,005

  1. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease
    Hana N. Dawson, Viviana Cantillana, Marilyn Jansen, H. Wang, Michael Peter Vitek, Donna M. Wilcock, John Lynch, Daniel T. Laskowitz · 2010 · Neuroscience
  2. The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity
    Sharma, Anuj K., Pavlova, Stephanie T., Kim, Jaekwang, Kim, Jungsu, Mirica, Liviu M. · 2013 · Metallomics
  3. A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress–mediated mitochondrial injury
    Pradoldej M Sompol, Wanida Ittarat, Jitbanjong Tangpong, Yumin Chen, I E Doubinskaia, I. Batinic-Haberle, Hafiz Mohmmad Abdul, David Allan Butterfield, Daret K. St. Clair · 2008 · Neuroscience
  4. Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease
    Tao Ma, Eric Klann · 2011 · Journal of Neurochemistry
  5. Insulin dysfunction and Tau pathology
    Noura B. El Khoury, Maud Gratuze, Marie-Amélie Papon, Alexis Bretteville, Emmanuel Planel · 2014 · Frontiers in Cellular Neuroscience
  6. Impact of membrane curvature on amyloid aggregation
    Mayu S. Terakawa, Yuxi Lin, Misaki Kinoshita, Shingo Kanemura, Dai Itoh, Toshihiko Sugiki, Masaki Okumura, Ayyalusamy Ramamoorthy, Young‐Ho Lee · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  7. Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells
    Soraya Santana, Marı́a Recuero, Maria Jesus Bullido, Fernando Valdivieso, Jesús Aldudo · 2011 · Neurobiology of Aging
  8. Calcium Ions Promote Formation of Amyloid β-Peptide (1–40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease
    Anna Itkin, Vincent Duprès, Yves F. Dufrêne, Burkhard Bechinger, Jean‐Marie Ruysschaert, Vincent Raussens · 2011 · PLoS ONE
  9. Mechanisms of Amyloid‐Beta Peptide Uptake by Neurons: The Role of Lipid Rafts and Lipid Raft‐Associated Proteins
    Aaron Y. Lai, JoAnne McLaurin · 2010 · International Journal of Alzheimer s Disease
  10. Tetraspanin12 regulates ADAM10‐dependent cleavage of amyloid precursor protein
    Xu, Daosong, Sharma, Chandan, Hemler, Martin E. · 2009 · The FASEB Journal
  11. Amyloid Precursor Protein Is a Primary Androgen Target Gene That Promotes Prostate Cancer Growth
    Ken‐ichi Takayama, Shuichi Tsutsumi, Takashi Suzuki, Kuniko Horie‐Inoue, Kazuhiro Ikeda, Kiyofumi Kaneshiro, Tetsuya Fujimura, Jinpei Kumagai, Tomohiko Urano, Yoshiyuki Sakaki et al. · 2008 · Cancer Research
  12. Intracellular amyloid toxicity induces oxytosis/ferroptosis regulated cell death
    Ling Huang, Daniel B. McClatchy, Pamela A Maher, Zhibin Liang, Jolene K. Diedrich, David Soriano‐Castell, Joshua Goldberg, Maxim Nikolaievich Shokhirev, John R. Yates, David A. Schubert et al. · 2020 · Cell Death and Disease
  13. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer’s disease
    Guzmán-Ramos, Kioko, Moreno-Castilla, Perla, Castro-Cruz, Monica, McGaugh, James L., Martínez-Coria, Hilda, LaFerla, Frank M., Bermúdez-Rattoni, Federico · 2012 · Learning & Memory
  14. The E693Δ Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid β Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells
    Nishitsuji, Kazuchika, Tomiyama, Takami, Ishibashi, Kenichi, Ito, Kazuhiro, Teraoka, Rie, Lambert, Mary P., Klein, William L., Mori, Hiroshi · 2009 · The American Journal of Pathology
  15. Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations
    Tampellini, Davide, Rahman, Nawreen, Gallo, Eduardo F., Huang, Zhenyong, Dumont, Magali, Capetillo-Zarate, Estibaliz, Ma, Tao, Zheng, Rong, Lu, Bao, Nanus, David M. et al. · 2009 · The Journal of Neuroscience
  16. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner
    Gannon, Olivia J., Robison, Lisa S., Salinero, Abigail E., Abi-Ghanem, Charly, Mansour, Febronia M., Kelly, Richard D., Tyagi, Alvira, Brawley, Rebekah R., Ogg, Jordan D., Zuloaga, Kristen L. · 2022 · Journal of Neuroinflammation
  17. Mitochondrial Ca2+ and neurodegeneration
    Tito Calí, Denis Ottolini, Marisa Brini · 2012 · Cell Calcium
  18. ABCA7 and Pathogenic Pathways of Alzheimer’s Disease
    Tomonori Aikawa, Marie‐Louise Holm, Takahisa Kanekiyo · 2018 · Brain Sciences
  19. Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment
    Leonardo Iaccarino, Renaud La Joie, Orit H. Lesman‐Segev, Eunice Y. Lee, Lucy Hanna, Isabel Elaine Allen, Bruce E. Hillner, Barry Alan Siegel, Rachel A. Whitmer, María C. Carrillo et al. · 2020 · JAMA Neurology
  20. Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues
    Alireza Majdi, Saeed Sadigh‐Eteghad, Sepideh Rahigh Aghsan, Fereshteh Farajdokht, Seyed Mehdi Vatandoust, Ali Namvaran Abbas-Abad, Javad Mahmoudi · 2020 · Reviews in the Neurosciences
  21. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction
    Ming‐Chang Chiang, Yi‐Chuan Cheng, Shiang‐Jiuun Chen, Chiahui Yen, Rong Huang · 2016 · Experimental Cell Research
  22. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains
    Valerie Askanas, W. King Engel · 2008 · Acta Neuropathologica
  23. Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides
    Jeppe T. Pedersen, Jesper Østergaard, Noémi Rozlosnik, Bente Gammelgaard, Niels H. H. Heegaard · 2011 · Journal of Biological Chemistry
  24. Design, synthesis and anti-Alzheimer’s activity of novel 1,2,3-triazole-chromenone carboxamide derivatives
    Arezoo Rastegari, Hamid Nadri, Mohammad Reza Mahdavi, Alireza Moradi, Seyedeh Sara Mirfazli, Najmeh Edraki, Farshad Homayouni Moghadam, Bagher A. Larijani, Tahmineh Akbarzadeh, Mina Saeedi · 2018 · Bioorganic Chemistry
  25. Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
    Daniel Robert Dries, Gang Yu · 2008 · Current Alzheimer Research
  26. Intracellular Accumulation of Amyloid- (A ) Protein Plays a Major Role in A -Induced Alterations of Glutamatergic Synaptic Transmission and Plasticity
    Cristian Ripoli, Sara Cocco, Domenica Donatella Li Puma, Roberto Piacentini, Alessia Mastrodonato, Federico Scala, Daniela Puzzo, Marcello D’Ascenzo, Claudio Grassi · 2014 · Journal of Neuroscience
  27. TOR on the brain
    Michael G. Garelick, Brian Keith Kennedy · 2010 · Experimental Gerontology
  28. Current therapeutic targets for the treatment of Alzheimer’s disease
    Joshua D. Grill, Jeffrey L. Cummings · 2010 · Expert Review of Neurotherapeutics
  29. Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
    Christensen, Ditte Z., Schneider-Axmann, Thomas, Lucassen, Paul J., Bayer, Thomas A., Wirths, Oliver · 2010 · Acta Neuropathologica
  30. Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila
    Zhao, Xiao-Liang, Wang, Wen-An, Tan, Jiang-Xiu, Huang, Jian-Kang, Zhang, Xiao, Zhang, Bao-Zhu, Wang, Yu-Hang, YangCheng, Han-Yu, Zhu, Hong-Lian, Sun, Xiao-Jiang et al. · 2010 · The Journal of Neuroscience
  31. Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer’s Disease
    Zhiren Wang, Yali Wang, Bo Wang, Wenrui Li, Ling Huang, Xingshu Li · 2015 · Journal of Medicinal Chemistry
  32. Norepinephrine Inhibits Alzheimer’s Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study
    Yu Feng Zou, Zhenyu Qian, Yujie Chen, Hongsheng Qian, Guanghong Wei, Qingwen Zhang · 2019 · ACS Chemical Neuroscience
  33. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
    Renato X. Santos, Sónia C. Correia, Xinglong Wang, George L. Perry, Mark A. Smith, Paula Isabel Moreira, Xiongwei Zhu · 2010 · Europe PMC (PubMed Central)
  34. Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease
    Géraldine Poisnel, Anne‐Sophie Hérard, Nadine El Tannir El Tayara, Emmanuel Bourrin, Andreas Volk, Frank Kober, Benoı̂t Delatour, Thierry Delzescaux, Thomas Debeir, Thomas Rooney et al. · 2011 · Neurobiology of Aging
  35. YAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology
    Tanaka, Hikari, Homma, Hidenori, Fujita, Kyota, Kondo, Kanoh, Yamada, Shingo, Jin, Xiaocen, Waragai, Masaaki, Ohtomo, Gaku, Iwata, Atsushi, Tagawa, Kazuhiko et al. · 2020 · Nature Communications
  36. Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils
    Sonia Freire, Marcus Henrique de Araujo, Wajih Al‐Soufi, Mercedes Novo · 2014 · Dyes and Pigments
  37. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
    Meakin, Paul J., Harper, Alex J., Hamilton, D. Lee, Gallagher, Jennifer, McNeilly, Alison D., Burgess, Laura A., Vaanholt, Lobke M., Bannon, Kirsten A., Latcham, Judy, Hussain, Ishrut et al. · 2012 · Biochemical Journal
  38. APP/Aβ structural diversity and Alzheimer's disease pathogenesis
    Alex E. Roher, Tyler A. Kokjohn, Steven Gerard Clarke, Michael R. Sierks, Chera L. Maarouf, Geidy E. Serrano, Marwan Sabbagh, Thomas G. Beach · 2017 · Neurochemistry International
  39. Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
    Inês Baldeiras, Isabel J. Santana, Maria João Leitão, Helena Gens, Rui Pascoal, Miguel Tábuas‐Pereira, José Beato-Coelho, Diana Duro, Maria Rosário Almeida, Catarina Resende Oliveira · 2018 · Alzheimer s Research & Therapy
  40. Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis
    Mahua Maulik, David A. Westaway, Jack H. Jhamandas, Satyabrata Kar · 2012 · Molecular Neurobiology
  41. Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
    Vega García‐Escudero, Patricia Martín-Maestro, George L. Perry, Jesús Ávila · 2013 · Oxidative Medicine and Cellular Longevity
  42. The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-βProduction in Alzheimer’s Disease
    Li Zuo, Benjamin T. Hemmelgarn, Chia‐Chen Chuang, Thomas Michael Best · 2015 · Oxidative Medicine and Cellular Longevity
  43. NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
    Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, Mst. Marium Begum, Shammi Akhter, Ariful Islam, Bijo Mathew, Md. Siddiqul Islam, Md. Shah Amran, Ghulam Md Ashraf · 2019 · Current Pharmaceutical Design
  44. Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer’s disease
    Qiang Gao, Yuan Wang, Xin Wang, Shuang Fu, Xin Zhang, Ruitao Wang, Xin Zhang · 2019 · Aging
  45. Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease
    Md. Sahab Uddin, Wing Shan Yu, Lee Wei Lim · 2021 · Ageing Research Reviews
  46. How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?
    Yuna Kim, Jihyun Park, Hyojin Lee, Jwa‐Min Nam · 2016 · Scientific Reports
  47. Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levels
    Yu-Qian Zhang, Kevin D. Sarge · 2008 · Biochemical and Biophysical Research Communications
  48. Role of Serotonin in Alzheimerʼs Disease: A New Therapeutic Target?
    Geldenhuys, Werner J., Van der Schyf, Cornelis J. · 2011 · CNS Drugs
  49. Dynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative Diseases
    Gabriele Giachin, Romain Bouverot, Samira Acajjaoui, Serena Pantalone, Montserrat Soler‐López · 2016 · Frontiers in Molecular Biosciences
  50. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease
    Leili Jalili‐Baleh, Elaheh Babaei, Shahin Abdpour, Syed Nasir Abbas Bukhari, Alireza Foroumadi, Ali Ramazani, Mohammad Sharif Sharifzadeh, Mohammad Reza Abdollahi, Mehdi Khoobi · 2018 · European Journal of Medicinal Chemistry
  51. Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer’s Disease
    Reddy, P. Hemachandra, Manczak, Maria, Yin, XiangLing · 2017 · Journal of Alzheimer s Disease
  52. Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal Aβ42 Uptake and Lysosomal Trafficking
    Fuentealba, Rodrigo A., Liu, Qiang, Zhang, Juan, Kanekiyo, Takahisa, Hu, Xiaoyan, Lee, Jin-Moo, LaDu, Mary Jo, Bu, Guojun · 2010 · PLoS ONE
  53. Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy
    Justin Zaghi, Benjamin Goldenson, Mohammed Inayathullah, A. S. Lossinsky, Ava Masoumi, Hripsime Avagyan, Michelle Mahanian, Michael J. Bernas, Martin E. Weinand, Mark J. Rosenthal et al. · 2009 · Acta Neuropathologica
  54. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
    Tai, Leon M, Mehra, Shipra, Shete, Varsha, Estus, Steve, Rebeck, G William, Bu, Guojun, LaDu, Mary Jo · 2014 · Molecular Neurodegeneration
  55. Role of matrix metalloproteinase-3 in neurodegeneration
    Eun‐Mee Kim, Onyou Hwang · 2010 · Journal of Neurochemistry
  56. The unfolded protein response in Alzheimer’s disease
    Víctor Hugo Cornejo, Claudio A. Hetz · 2013 · Seminars in Immunopathology
  57. Amyloid-β Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2
    Claire L. Russell, Sophia Semerdjieva, Ruth M. Empson, Brian Austen, Philip W Beesley, Pavlos Alifragis · 2012 · PLoS ONE
  58. Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1–42) compared to Aβ(1–40)
    Emelie V. Wesén, Gavin D. M. Jeffries, Maria Matson Dzebo, Elin K. Esbjörner · 2017 · Scientific Reports
  59. MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update
    Subodh Kumar, P. Hemachandra Reddy · 2018 · Frontiers in Aging Neuroscience
  60. The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease
    Dong Liu, M. G. R. PITTA, Jong-Hwan Lee, Balmiki Ray, Debomoy K. Lahiri, Katsutoshi Furukawa, Mohamed R. Mughal, Haiyang Jiang, Julissa S. Villarreal, Roy G. Cutler et al. · 2010 · Journal of Alzheimer s Disease
  61. β-Amyloid Modulation of Synaptic Transmission and Plasticity
    Deepa V. Venkitaramani, Jeannie Chin, William J. Netzer, Gunnar K. Gouras, Sylvain Lesné, Roberto Malinow, Paul J. Lombroso · 2007 · Journal of Neuroscience
  62. Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: How important is BDNF ?
    Anthony Markham, Rasneer Sonia Bains, P Franklin, Michael Spedding · 2013 · British Journal of Pharmacology
  63. Treadmill exercise represses neuronal cell death and inflammation during Aβ-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice
    Eun‐Bum Kang, Insu Kwon, Jung‐Hoon Koo, Eung-Joon Kim, Chul‐Hyun Kim, Jin Lee, Choon-Ho Yang, Young-Il Lee, In‐Ho Cho, Joon‐Yong Cho · 2013 · APOPTOSIS
  64. Phytosterols: Potential Metabolic Modulators in Neurodegenerative Diseases
    Niti Sharma, Mario A. Tan, Seong Soo A. An · 2021 · International Journal of Molecular Sciences
  65. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo
    Maria Francesca Cordeiro, Li Guo, Katy M. Coxon, James Duggan, Shereen Nizari, Eduardo Maria Normando, Stefano Luca Sensi, Adam Murdin Sillito, Frederick W. Fitzke, T.E. Salt et al. · 2010 · Cell Death and Disease
  66. A broadly neuroprotective derivative of curcumin
    Yuanbin Liu, Richard Dargusch, Pamela A Maher, David A. Schubert · 2008 · Journal of Neurochemistry
  67. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease
    Faure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., Delatour, B. · 2011 · Neurobiology of Aging
  68. Infection, systemic inflammation, and Alzheimer's disease
    Sharon Lim, Carlos J. Rodríguez‐Ortiz, Masashi Kitazawa · 2015 · Microbes and Infection
  69. Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies
    Parmenion P. Tsitsopoulos, Niklas Marklund · 2013 · Frontiers in Neurology
  70. Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity
    Lila K. Habib, Michelle T.C. Lee, Jerry Yang · 2010 · Journal of Biological Chemistry
  71. The storm before the quiet: neuronal hyperactivity and aβ in the presymptomatic stages of Alzheimer’s disease
    Stargardt, Anita, Swaab, Dick F., Bossers, Koen · 2015 · Neurobiology of Aging
  72. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer’s disease
    Choi, Bo-Ryoung, Cho, Woo-Hyun, Kim, Jiyoung, Lee, Hyong Joo, Chung, ChiHye, Jeon, Won Kyung, Han, Jung-Soo · 2014 · Experimental & Molecular Medicine
  73. Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake
    Sidhartha M. Chafekar, Frank Baas, Wiep Scheper · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  74. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety
    Samaneh Ghanei Nasab, Mehdi Khoobi, Farzin Hadizadeh, Azam Marjani, Alireza Moradi, Hamid Nadri, Saeed Emami, Alireza Foroumadi, Abbas Shafiee · 2016 · European Journal of Medicinal Chemistry
  75. Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level, and synaptic deficits in Alzheimer’s disease
    Li, Bo, Liu, Jianhui, Gu, Guojun, Han, Xu, Zhang, Qi, Zhang, Wei · 2020 · Journal of Neurochemistry
  76. Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders
    Caruso, Giuseppe, Caraci, Filippo, Jolivet, Renaud B. · 2019 · Progress in Neurobiology
  77. Amyloid β-peptides interfere with mitochondrial preprotein import competence by a coaggregation process
    Giovanna Cenini, Cornelia Rüb, Michael Bruderek, Wolfgang Voos · 2016 · Molecular Biology of the Cell
  78. ESC-Derived Basal Forebrain Cholinergic Neurons Ameliorate the Cognitive Symptoms Associated with Alzheimer’s Disease in Mouse Models
    Wei Yue, Yuanyuan Li, Ting Zhang, Man Jiang, Yun Qian, Min Zhang, Nengyin Sheng, Su Feng, Ke Tang, Xiang Yu et al. · 2015 · Stem Cell Reports
  79. Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review
    Shuguang Wang, Dongxiao Sun‐Waterhouse, Geoffrey I. N. Waterhouse, Lin Ping Zheng, Guowan Su, Mouming Zhao · 2021 · Trends in Food Science & Technology
  80. Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease
    Bernardo, T.C., Marques‐Aleixo, I., Beleza, J., Oliveira, P.J., Ascensão, A., Magalhães, J. · 2016 · Brain Pathology
  81. Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy
    Valerie Askanas, W. King Engel, Anna Nogalska · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  82. Alzheimer, mitochondria and gender
    Amandine Grimm, Ayikoe Guy Mensah‐Nyagan, Anne Eckert · 2016 · Neuroscience & Biobehavioral Reviews
  83. Amyloid-β and Alzheimer’s disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions
    Ambra A. Grolla, Joan A. Sim, Dmitry Lim, Jose Julio Rodriguez, Armando A. Genazzani, Alexei Verkhratsky · 2013 · Cell Death and Disease
  84. Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
    Herman Moreno, Eunah Yu, Gustavo F. Pigino, Alejandro Ivan Hernandez, Natalia Kim, Jorge E. Moreira, Mutsuyuki Sugimori, Rodolfó R. Llinás · 2009 · Proceedings of the National Academy of Sciences
  85. Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease
    Rangappa Sangappa Keri, Catarina Quintanova, Sérgio M. Marques, A. Raquel Esteves, Sandra M. Cardoso, Maria Amélia Santos · 2013 · Bioorganic & Medicinal Chemistry
  86. Biomarkers in Sporadic and Familial Alzheimer’s Disease
    Lista, Simone, O’Bryant, Sid E., Blennow, Kaj, Dubois, Bruno, Hugon, Jacques, Zetterberg, Henrik, Hampel, Harald · 2015 · Journal of Alzheimer's Disease
  87. Synaptic activity and Alzheimer's disease: a critical update
    Davide Tampellini · 2015 · Frontiers in Neuroscience
  88. Cinnamon, a promising prospect towards Alzheimer’s disease
    Saeideh Momtaz, Shokoufeh Hassani, Fazlullah Khan, Mojtaba Ziaee, Mohammad Reza Abdollahi · 2017 · Pharmacological Research
  89. A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
    Ola Philipson, Per Hammarström, K. Peter R. Nilsson, Erik Portelius, Tommie Olofsson, Martin Ingelsson, Bradley T. Hyman, Kaj Blennow, Lars Lannfelt, Hannu Kalimo et al. · 2008 · Neurobiology of Aging
  90. APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
    Leslie A. Crews, Edward M. Rockenstein, Eliezer Masliah · 2009 · Brain Structure and Function
  91. The Development of New Therapeutics for Alzheimer's Disease
    M D Carter, Gordon A. Simms, Donald Fredric Weaver · 2010 · Clinical Pharmacology & Therapeutics
  92. Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
    Jonathan Chang-Cheng Shieh, Pai-Tsang Huang, Yung‐Feng Lin · 2020 · Molecular Neurobiology
  93. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape
    Antero Salminen, Annakaisa Haapasalo, Anu Kauppinen, Kai Kaarniranta, Hilkka S. Soininen, Mikko O. Hiltunen · 2015 · Progress in Neurobiology
  94. Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus
    Daniel J. Whitcomb, Ellen L. Hogg, Philip L. Regan, Thomas M. Piers, Priyanka S. Narayan, Garry Whitehead, Bryony L. Winters, Dong-Hyun Kim, Eunjoon Kim, Peter St George‐Hyslop et al. · 2015 · Scientific Reports
  95. Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium
    Irina I. Alafuzoff, Maria Pikkarainen, Thomas Arzberger, Dietmar Rudolf Thal, Safa Al‐Sarraj, Jeanne E. Bell, István Bódi, Herbert Budka, Estibaliz Capetillo‐Zarate, Isidró Ferrer et al. · 2008 · Acta Neuropathologica
  96. The effects of cholesterol on learning and memory
    Bernard G. Schreurs · 2010 · Neuroscience & Biobehavioral Reviews
  97. Cellular Polyamines Promote Amyloid-Beta (Aβ) Peptide Fibrillation and Modulate the Aggregation Pathways
    Jinghui Luo, Chien‐Hung Yu, Huixin Yu, Rok Borštnar, Shina Caroline Lynn Kamerlin, Astrid Gräslund, Jan Pieter Abrahams, Sebastian K.T.S. Wärmländer · 2013 · ACS Chemical Neuroscience
  98. Autophagy: A double-edged sword in Alzheimer’s disease
    Ying-Tsen Tung, Bo‐Jeng Wang, Ming‐Kuan Hu, Wen‐Ming Hsu, Hsinyu Lee, Wei‐Pang Huang, Yung‐Feng Liao · 2012 · Journal of Biosciences
  99. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
    Juvenal A. Ríos, Pedro Cisternas, Marco A. Arrese, Salesa Barja Y., Nibaldo C. Inestrosa · 2014 · Progress in Neurobiology
  100. Back to the Future with Phenotypic Screening
    Marguerite Prior, Chandramouli Chiruta, Antonio Jose Martins Currais, Josh Goldberg, Justin Ramsey, Richard Dargusch, Pamela A Maher, David A. Schubert · 2014 · ACS Chemical Neuroscience